4 year Tecfidera clinical efficacy and safety data

Discuss Tecfidera (BG-12, dimethyl fumarate) as an oral treatment for multiple sclerosis.

4 year Tecfidera clinical efficacy and safety data

Postby MSUK » Fri Oct 18, 2013 7:29 am

4 year Tecfidera clinical efficacy and safety data in patients with MS released

Latest results from the clinical trial program with BG-12 (dimethyl fumarate; Tecfidera, Biogen Idec) suggest sustained clinical efficacy and safety in patients with multiple sclerosis (MS) taking the drug for up to 4 years.

In addition, a separate post hoc analysis of the phase 3 pivotal Determination of the Efficacy and Safety of Oral Fumarate in Relapsing–Remitting MS (DEFINE) and Comparator and an Oral Fumarate in Relapsing–Remitting Multiple Sclerosis (CONFIRM) clinical trials shows that BG-12 reduced relapses and disease activity in treatment-naive patients...... Read More - http://www.ms-uk.org/BG12
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2178
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Tecfidera (BG-12, dimethyl fumarate)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service